Key facts
- It has raised $6.3M; the latest was PE Growth/Expansion in Feb 2026.
- Notable investors include Seae Ventures, Blue Haven Initiative, Downing Capital Group.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Bloomwell Autism Therapy
- ·The full record, as it builds
Funding rounds
No funding rounds for Bloomwell Autism Therapy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bloomwell Autism Therapy
Operator of a mental health care firm intended to provide applied behavior analysis (ABA) therapy for autism. The company creates personalized treatment plans to help unlock new skills and abilities, such as improving communication and language skills, replacing challenging behavior with safe and appropriate behavior, gaining independence, and preparing for a school environment, enabling children to learn new skills and improve their confidence.
- Sector
- Healthcare
- HQ
- Mendota Heights, MN, United States
- Founded
- 2024
- Employees
- 53
- Website
- bloomwellcare.com/
- Ownership
- Privately Held (backing)
Bloomwell Autism Therapy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bloomwell Autism Therapy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bloomwell Autism Therapy in its N-PORT filings yet. We sweep new filings monthly.